TUCSON, Ariz.--(EON: Enhanced Online News)--BioDirection, Inc., a developer of point-of-care brain injury screening and monitoring devices to separate minor head injuries from mild traumatic head injury, announced today that Robert B. Reid has joined the Company as Vice President, Global Marketing.
“Robert is a proven strategic marketing executive with extensive experience in both early stage and high growth Fortune 500 healthcare companies across multiple disease states and medical specialties. Robert has over 25 years of deep experience in new product development and global commercialization of diagnostic and therapeutic medical devices”
“Robert is a proven strategic marketing executive with extensive experience in both early stage and high growth Fortune 500 healthcare companies across multiple disease states and medical specialties. Robert has over 25 years of deep experience in new product development and global commercialization of diagnostic and therapeutic medical devices,” said Brian McGlynn, President & CEO of BioDirection. “Robert has long demonstrated his hands-on-approach and leadership within fast-paced and entrepreneurial environments and has driven new revenue streams in domestic and international markets. He is an ideal fit for BioDirection as we prepare to launch our first point-of-care products later this year.”
Prior to joining BioDirection, Reid had an extensive career with Boston Scientific (BSC), holding multiple executive marketing and program management positions, most notably having led the formation and launch of the company’s neurointerventional division. After Boston Scientific, he founded L.B. Marketing, a consulting firm advising companies on branding and increasing market share. Reid later went on to hold the position of Vice President at Informed Clinical Sciences, a Boston- based entrepreneurial E-Health Company. There he was instrumental in the rapid growth of The Endovascular Forum.org, now one of the world’s largest online doctor-to-doctor platforms for sharing complex and pioneering cases. Reid also held the position of Global Director Strategic and Lifecycle Marketing at Covidien and most recently, he worked with the Boston Children’s Hospital Heart Center in the development of their strategic marketing plan. Reid holds a Bachelor of Science Business Degree from the University of Maryland, Robert H. Smith School of Business, and is a long-time coach for Special Olympics.
BioDirection, Inc. is a privately-held medical device company focused on the design, development and commercialization of easy-to-use, low cost and portable point-of-care biomarker devices for screening and monitoring of acquired brain injury. The company’s strategy is to blend proven science with innovative technology to create diagnostic tools to address critical market needs. For more information, visit http://www.biodirection.com.